NeuroDirect

Psycheceutical Bioscience, Inc (OTCPK: BWVI) is a cutting-edge biotech startup that developed a topical drug delivery system called NeuroDirect, a system that can be used to deliver psychedelic drugs directly to the brain, avoiding the traditional “high” and side effects. The...

Mike ‘Zappy’ Zapolin, Chief Visionary Officer of Psycheceutical Bioscience, Inc (OTCPK: BWVI), whom we'll call Zappy, shared his vision for the future of psychedelics at the recent Benzinga Psychedelics Capital Conference in Miami. He also...

Biotech company Psycheceutical Bioscience Inc. (OTC: BWVI) has published observational data supporting the potential of its proprietary ketamine topical cream NeuroDirect for the treatment of PTSD.  Observational data were collected in a non-clinical setting from an outpa­tient...

Publicly traded psychedelics company Psycheceutical Bioscience Inc. (OTC: BWVI) is signing an exclusive purchase option with end-to-end pharma R&D company Vici Health Sciences’ majority equity stake. The company develops cutting-edge gear and novel compounds for next-gen mental health...